세계의 반려동물용 바이오 보안 솔루션 시장 예측(-2032년) : 제품 종류별, 용도별, 최종사용자별, 지역별 분석

According to Stratistics MRC, the Global Pet Biosecurity Solutions Market is accounted for $9.3 billion in 2025 and is expected to reach $26.8 billion by 2032 growing at a CAGR of 16.3% during the forecast period. Pet Biosecurity Solutions are systems and practices aimed at preventing the spread of infectious diseases among pets. These include hygiene protocols, vaccination programs, quarantine procedures, and monitoring tools that help detect and control health risks. The goal is to protect animals from pathogens and ensure safe environments in homes, clinics, shelters, and public spaces. Solutions may involve physical barriers, sanitation products, and digital tracking of health data to maintain wellness and prevent outbreaks.

According to the World Organisation for Animal Health, rising zoonotic disease threats are accelerating demand for advanced diagnostics, vaccines, and disinfection protocols to secure facilities like kennels and veterinary hospitals.

Market Dynamics:

Driver:

Rising zoonotic disease awareness

The Pet Biosecurity Solutions Market is being driven by increasing awareness of zoonotic diseases and the critical need to protect both pets and humans from cross-species infections. Fueled by global health initiatives and heightened pet hygiene standards, owners are prioritizing preventive care and sanitation products. Rising media coverage of outbreaks such as rabies and leptospirosis further reinforces demand. Additionally, veterinary professionals emphasize early detection and containment practices, accelerating product adoption. Consequently, biosecurity solutions are becoming indispensable in pet care.

Restraint:

Limited consumer awareness

Limited awareness among pet owners regarding biosecurity measures acts as a key restraint in market expansion. Many consumers remain unaware of infection control practices beyond routine vaccinations. This knowledge gap hinders adoption of preventive hygiene products like disinfectants, sanitizers, and antimicrobial bedding. Furthermore, insufficient education campaigns and product accessibility in emerging regions exacerbate the issue. Overcoming this restraint requires targeted outreach by veterinary organizations and manufacturers to promote the importance of proactive pet biosecurity.

Opportunity:

Development of innovative hygiene products

The development of advanced and innovative hygiene solutions presents significant opportunities in the Pet Biosecurity Solutions Market. Spurred by advancements in biotechnology and materials science, companies are introducing long-lasting disinfectants, pathogen-specific sprays, and eco-friendly sanitizers. These innovations cater to the growing preference for non-toxic and sustainable products among pet owners. Additionally, integration of smart packaging and automated hygiene systems in veterinary settings enhances safety and convenience. This technological evolution is expected to redefine preventive pet health management.

Threat:

Alternative preventive measures

Alternative preventive measures such as vaccines, immune-boosting supplements, and natural remedies pose a notable threat to market growth. Many pet owners prefer these solutions due to their familiarity and perceived lower cost. Moreover, traditional disinfection practices like frequent grooming or herbal cleaning reduce dependence on specialized biosecurity products. This substitution effect may limit product penetration, particularly in cost-sensitive markets. Manufacturers must emphasize proven efficacy and safety advantages to counter competition from alternative preventive approaches.

Covid-19 Impact:

The COVID-19 pandemic significantly heightened awareness of hygiene and pathogen transmission among pet owners, accelerating adoption of biosecurity solutions. Initially, disruptions in supply chains and veterinary services hampered product availability. However, rising concerns over pet-related disease vectors boosted sales of sanitizers, disinfectants, and protective equipment. Post-pandemic recovery saw increased institutional adoption of hygiene protocols in shelters and clinics. Consequently, COVID-19 served as a catalyst for the long-term institutionalization of pet biosecurity practices worldwide.

The disinfectants & sanitizers segment is expected to be the largest during the forecast period

The disinfectants & sanitizers segment is expected to account for the largest market share during the forecast period, resulting from their critical role in eliminating harmful pathogens from pet environments. These products are extensively used in clinics, shelters, and households to reduce disease transmission risk. Growing awareness of pet hygiene and safe handling practices further enhances demand. Additionally, innovations in alcohol-free, pet-safe formulations support sustained adoption. This segment's reliability and broad applicability solidify its dominant market position.

The veterinary clinics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the veterinary clinics segment is predicted to witness the highest growth rate, propelled by rising implementation of strict sanitation standards and infection control measures. Veterinary professionals increasingly rely on biosecurity solutions to safeguard animals and staff from cross-contamination. Clinics are adopting advanced disinfectants, sterilization tools, and isolation protocols to comply with regulatory guidelines. Moreover, growing pet treatment volumes and awareness of hospital-acquired infections are accelerating adoption, making veterinary clinics a high-growth end-use segment.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, attributed to expanding pet ownership, rising disposable incomes, and growing veterinary infrastructure in countries like China, Japan, and India. Heightened awareness of zoonotic diseases and government-driven animal health programs further stimulate market expansion. Additionally, increasing investments by global biosecurity companies strengthen regional product availability. These factors collectively position Asia Pacific as a major hub for pet biosecurity solution adoption.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR associated with advanced veterinary healthcare systems, high pet expenditure, and early adoption of hygiene innovations. The U.S. and Canada are witnessing surging demand for premium biosecurity products supported by stringent animal health regulations. Furthermore, the strong presence of key market players and robust distribution networks enhances accessibility. Continuous product innovation and awareness campaigns are expected to sustain rapid market growth in the region.

Key players in the market

Some of the key players in Pet Biosecurity Solutions Market include 3M Company, Elanco Animal Health, BASF SE, Stockmeier Group, DuPont de Nemours, Inc., Kersia Group, Thermo Fisher Scientific Inc., Kemin Industries Inc., Ecolab Inc., Evonik Industries AG, Zoetis Inc., Solvay S.A., Neogen Corporation, BASF Animal Nutrition, Lanxess AG, Bayer Animal Health, GEA Group Aktiengesellschaft, and Merck Animal Health.

Key Developments:

In September 2025, Zoetis presented new data on BRAVECTO(R) injectable at WSAVA Congress, highlighting rapid onset and safety. The company also donated its 7 millionth rabies vaccine through the Afya Program

In August 2025, Lanxess AG showcased Virkon(R), TH4+(R), and Hyperox(R) at IPPE 2025, reinforcing its leadership in animal biosecurity. The company emphasized sustainability and compliance in poultry and livestock hygiene

In April 2025, Stockmeier Group expanded its disinfectant portfolio in India via Saife Vetmed, launching enzymatic cleaners for livestock and companion animals. The collaboration targets Southeast Asia, Middle East, and Africa

Product Types Covered:

• Disinfectants & Sanitizers
• Pest & Parasite Control Products
• Vaccines & Diagnostics
• Air & Waste Management Systems
• Monitoring & Tracking Devices

Applications Covered:

• Veterinary Clinics
• Animal Shelters
• Pet Boarding Facilities
• Households

End Users Covered:

• Pet Owners
• Veterinarians
• Animal Care Organizations

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Pet Biosecurity Solutions Market, By Product Type

• 5.1 Introduction
• 5.2 Disinfectants & Sanitizers
• 5.3 Pest & Parasite Control Products
• 5.4 Vaccines & Diagnostics
• 5.5 Air & Waste Management Systems
• 5.6 Monitoring & Tracking Devices

6 Global Pet Biosecurity Solutions Market, By Application

• 6.1 Introduction
• 6.2 Veterinary Clinics
• 6.3 Animal Shelters
• 6.4 Pet Boarding Facilities
• 6.5 Households

7 Global Pet Biosecurity Solutions Market, By End User

• 7.1 Introduction
• 7.2 Pet Owners
• 7.3 Veterinarians
• 7.4 Animal Care Organizations

8 Global Pet Biosecurity Solutions Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 3M Company
• 10.2 Elanco Animal Health
• 10.3 BASF SE
• 10.4 Stockmeier Group
• 10.5 DuPont de Nemours, Inc.
• 10.6 Kersia Group
• 10.7 Thermo Fisher Scientific Inc.
• 10.8 Kemin Industries Inc.
• 10.9 Ecolab Inc.
• 10.10 Evonik Industries AG
• 10.11 Zoetis Inc.
• 10.12 Solvay S.A.
• 10.13 Neogen Corporation
• 10.14 BASF Animal Nutrition
• 10.15 Lanxess AG
• 10.16 Bayer Animal Health
• 10.17 GEA Group Aktiengesellschaft
• 10.18 Merck Animal Health